Lipotropic injections have been a fixture of medical weight loss for decades, and they are one of the most requested cash-pay services in aesthetic and wellness practices. They are also one of the most oversold. If you are deciding whether to offer MIC in your practice — or fielding patients who arrive asking for “the fat burning shot” — the useful question is not what MIC does in theory. It is what the evidence actually supports, and where a nutrient injection still fits now that GLP-1 agonists exist.
This guide is written for practitioners. It covers the biochemistry, the evidence honestly, the regulatory status most articles skip, and how to position MIC with patients without promising something it cannot deliver.
What Lipotropic Injections Are
“Lipotropic” describes a compound that participates in the metabolism or transport of fat in the liver. The classic MIC formulation combines three of them:
- Methionine — an essential amino acid, a methyl donor, and a precursor in the pathways that package hepatic lipid for export.
- Inositol — a carbocyclic sugar involved in cell signalling and lipid handling. Frequently but inaccurately called “vitamin B8”; it is not a vitamin.
- Choline — an essential nutrient required for phosphatidylcholine synthesis, which is genuinely necessary for VLDL assembly and hepatic fat export.
Many formulations add vitamin B12 (cyanocobalamin), which is where the “MIC B12” or “lipo MIC” naming comes from. B12 is included for energy and because it is cheap, well tolerated and gives the injection a perceptible effect — though only patients who are actually deficient should expect a real energy change from it.
Do Lipotropic Injections Work? What the Evidence Actually Says
This is the section most pages ranking for this term avoid, and it is the one that matters clinically.
The biochemistry is real. Choline deficiency genuinely impairs hepatic fat export and is associated with hepatic steatosis. Methionine and choline are established players in one-carbon metabolism. None of that is in dispute.
The clinical leap is not established. There are no controlled trials of the combined MIC formulation demonstrating meaningful weight loss. The evidence does not show that supplying extra methionine, inositol and choline by injection to a patient who is not deficient produces weight loss on its own. “This nutrient is required for fat metabolism” and “injecting more of this nutrient causes fat loss” are different claims, and only the first is supported.
MIC injections are not FDA-approved for weight loss. They are unapproved compounded products, prepared by compounding pharmacies, which have not been reviewed by the FDA for safety, efficacy or quality in this indication. That is not a technicality — it determines how you may market them, what you must disclose, and what your consent process needs to cover.
None of this makes MIC useless or unethical to offer. It makes it an adjunct with a plausible mechanism and thin outcome data, delivered inside a supervised programme. Practitioners get into trouble when they describe it as a fat burner rather than as what it is.
Where MIC Fits Now That GLP-1s Exist
This is the question that has changed the category, and any guidance written before 2024 simply does not address it.
Semaglutide and tirzepatide produce weight loss of a magnitude that nutrient injections have never approached, with a real trial base behind them. A practitioner asking “should I offer MIC?” in 2026 is implicitly asking “why would I, when I can prescribe a GLP-1?”
The honest answers are narrower than the marketing, but they are real:
- Patients who cannot or will not take a GLP-1. Contraindications, intolerable GI effects, cost, or simple preference. A low-risk adjunct is better than disengagement.
- Programme adherence and contact. A weekly or twice-weekly injection visit creates a touchpoint — weigh-ins, accountability, coaching. Much of the observed benefit in MIC programmes plausibly comes from the programme, not the vial. That is worth being honest with yourself about, and it is still clinically useful.
- Adjunct alongside a GLP-1, where B12 or nutrient repletion is independently indicated.
- Practice economics. MIC is inexpensive, cash-pay and low-risk. That is a legitimate reason to offer it and an illegitimate reason to overstate it.
What MIC is not is a GLP-1 alternative for a patient who wants GLP-1 results. Setting that expectation at the consult prevents most of the disappointment in this category.
Candidacy and Contraindications
MIC is generally well tolerated. Reasonable candidates are patients already engaged in a supervised weight-loss programme with diet and activity in place, who understand it is adjunctive.
Exercise caution or avoid with:
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Medical Weight Loss & Metabolic Health courses — live patients, expert faculty, and ongoing mentorship.
- Pregnancy and breastfeeding — insufficient data.
- Hepatic or renal impairment — these are compounds handled by the liver and kidneys; involve the managing physician.
- Known sensitivity to any component, including cobalt/B12 hypersensitivity.
- Patients seeking MIC instead of evaluation. Unexplained weight gain deserves a workup, not a fat-burner shot. Thyroid disease, medication effects and sleep apnoea do not respond to lipotropics.
Protocol, Administration and Cost
MIC is given intramuscularly, typically into the deltoid or gluteal muscle, most commonly weekly, sometimes twice weekly early in a programme. Formulations are not standardised — concentrations vary by compounding pharmacy, which is one reason cross-clinic comparisons and published timelines are unreliable.
Adverse events are usually limited to injection-site reactions: transient soreness, redness, occasional bruising. Patients frequently report an energy change in the first day or two, which is most plausibly B12 in deficient patients, and expectation in everyone else.
Pricing is cash-pay and varies widely by market, commonly quoted per injection or as a package tied to a programme. Because it is inexpensive to source, the margin sits in the programme, not the vial — another reason to build MIC into supervised care rather than sell it as a standalone product.
How to Talk to Patients About MIC
The framing that holds up: “These are nutrients your liver uses to process fat. If you're low in them, topping them up helps that machinery work properly. What they don't do is burn fat on their own — the weight loss comes from the programme, and this supports it.”
What not to say: fat burner, melts fat, detoxifies the liver. “Detox” in particular has no clinical meaning and signals to an informed patient that the rest of your advice may not be rigorous.
Document that the patient understands MIC is adjunctive, compounded, and not FDA-approved for weight loss. That conversation protects the patient and it protects you.
Frequently Asked Questions
What are lipotropic injections?
Injections of compounds involved in hepatic fat metabolism — classically methionine, inositol and choline, often with vitamin B12. They are used as an adjunct within supervised medical weight-loss programmes, not as a standalone treatment.
Do lipotropic injections work?
For weight loss on their own, the evidence does not support it. There are no controlled trials of the combined formulation showing meaningful weight loss, and supplementing patients who are not deficient has not been shown to produce it. The underlying biochemistry is real; the clinical claim built on top of it outruns the data.
Are lipotropic injections safe?
Generally well tolerated, with injection-site reactions the most common adverse event. The more meaningful caveat is that they are unapproved compounded products, so formulation and quality vary by pharmacy — which makes your choice of compounder a clinical decision, not a purchasing one.
Do you need a prescription for lipotropic injections?
Yes. MIC is a compounded prescription product administered under medical supervision. Anything sold direct to consumers without a prescriber relationship should be treated as a red flag.
How long do lipotropic injections take to work?
There is no established clinical timeline, because the controlled trials that would establish one have not been done. Patients often report an energy change within days — largely attributable to B12 where deficiency exists. Any weight change tracks the programme, over weeks to months.
How much do lipotropic injections cost?
Cash-pay, varying widely by market, usually priced per injection or bundled into a programme. Sourcing cost is low, which is why the sustainable model builds them into supervised care rather than selling vials.
Are MIC injections the same as MIC B12 injections?
MIC is the methionine/inositol/choline base; many formulations add B12. We cover the B12 side in more depth in our guide to MIC B12 injections and weight loss shots.
Training in Medical Weight Loss
Lipotropics are one small tool in a field that has been reshaped by GLP-1 agonists, and the practitioners doing well are the ones who understand where each option genuinely fits. Empire Medical Training's Advanced Weight Management Certification covers GLP-1 agonists including semaglutide alongside the wider medical weight-loss toolkit, taught for practitioners building or expanding a supervised programme.
